
Blis Technologies Limited — Investor Relations & Filings
Blis Technologies Limited specializes in the research, development, and commercialization of advanced probiotic strains specifically designed for oral health. The company focuses on the oral microbiome, utilizing patented strains of Streptococcus salivarius, most notably BLIS K12 and BLIS M18. These probiotics are engineered to support the natural immune defenses of the mouth and throat, providing protection against common bacterial infections and promoting healthy teeth and gums. The company's product portfolio includes formulations for throat health, immune support, and dental hygiene, targeting both consumer retail and ingredient supply markets. By leveraging proprietary fermentation and stabilization technologies, the company delivers clinically backed solutions that aim to maintain a healthy microbial balance in the oral cavity.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Strong revenue and underlying earnings growth | 2026-05-20 | English | |
| Strong YTD performance | 2026-02-18 | English | |
| Changes in BLIS Board | 2026-02-08 | English | |
| Strong revenue and underlying earnings growth | 2025-11-26 | English | |
| Probi agreement enhanced to strengthen alliance | 2025-10-27 | English | |
| Two New Patents Strengthen BLIS Global IP Position | 2025-09-19 | English |
Browse filings by year
11 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GemVax & KAEL Co.,Ltd.
Clinical-stage biopharma developing therapeutics for neurod…
|
082270 | KR | Manufacturing |
|
Gencurix Inc.
Develops and commercializes diagnostic solutions for precis…
|
229000 | KR | Manufacturing |
|
GENEDRIVE PLC
Develops rapid, point-of-care pharmacogenetic testing platf…
|
GDR | GB | Manufacturing |
|
GENELUX Corp
Clinical-stage biopharma developing oncolytic viral immunot…
|
GNLX | US | Manufacturing |
|
GENEMATRIX INC.
Develops multiplex PCR diagnostic products for infectious d…
|
109820 | KR | Manufacturing |
|
Generation Bio Co.
Develops siRNA therapeutics delivered via ctLNPs for T cell…
|
GBIO | US | Manufacturing |
|
GENETIC SIGNATURES LIMITED
Molecular diagnostics company using proprietary 3base techn…
|
GSS | AU | Manufacturing |
|
Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics …
|
095700 | KR | Manufacturing |
|
Genfit S.A.
Biopharmaceutical firm developing therapies and diagnostics…
|
GNFT | US | Manufacturing |
|
GenFleet Therapeutics (Shanghai) Inc.
Clinical-stage biopharma specializing in first-in-class onc…
|
2595 | HK | Manufacturing |
Blis Technologies Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/66168/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=66168 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=66168 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=66168 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 66168}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Blis Technologies Limited (id: 66168)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.